Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy

The interdependence of transcript and protein abundance: new data-new complexities

(2016) Y. Liu et al.   Molecular Systems Biology

Gapped sequence alignment using artificial neural networks: application to the MHC class I system

(2015) Massimo Andreatta et al.   BIOINFORMATICS

A combined approach of human leukocyte antigen ligandomics and immunogenicity analysis to improve peptide-based cancer immunotherapy

(2015) Janet Kerstin Peper et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunotherapy for glioblastoma

(2015) Tobias Weiss et al.   CURRENT OPINION IN NEUROLOGY

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

(2015) Cyrille J. Cohen et al.   JOURNAL OF CLINICAL INVESTIGATION

Tumor neoantigens: building a framework for personalized cancer immunotherapy

(2015) Matthew M. Gubin et al.   JOURNAL OF CLINICAL INVESTIGATION

Landscape of Tumor Antigens in T Cell Immunotherapy

(2015) S. Ilyas et al.   JOURNAL OF IMMUNOLOGY

Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation

(2015) Michal Bassani-Sternberg et al.   MOLECULAR & CELLULAR PROTEOMICS

Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry

(2015) Etienne Caron et al.   MOLECULAR & CELLULAR PROTEOMICS

Combination cancer immunotherapy and new immunomodulatory targets

(2015) Kathleen M. Mahoney et al.   NATURE REVIEWS DRUG DISCOVERY

Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma

(2015) Richard G. Everson et al.   NEURO-ONCOLOGY

BioGPS: building your own mash-up of gene annotations and expression profiles

(2015) Chunlei Wu et al.   NUCLEIC ACIDS RESEARCH

2016 update of the PRIDE database and its related tools

(2015) Juan Antonio Vizcaíno et al.   NUCLEIC ACIDS RESEARCH

Glioblastoma multiforme: Pathogenesis and treatment

(2015) Constantinos Alifieris et al.   PHARMACOLOGY & THERAPEUTICS

Advances in high-resolution accurate mass spectrometry application to targeted proteomics

(2015) Antoine Lesur et al.   PROTEOMICS

Statistics requantitates the central dogma

(2015) J. J. Li et al.   SCIENCE

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

Immunogenicity of somatic mutations in human gastrointestinal cancers

(2015) E. Tran et al.   SCIENCE

Oncogenic cancer/testis antigens: prime candidates for immunotherapy

(2015) Morten F. Gjerstorff et al.   Oncotarget

Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions

(2015) Clovis S. Palmer et al.   Frontiers in Immunology

Trial Watch: Peptide-based anticancer vaccines

(2015) Jonathan Pol et al.   OncoImmunology

Potential of epigenetic therapies in the management of solid tumors

(2015) Víctor Manuel Valdespino-Gomez et al.   Cancer Management and Research

Classification of current anticancer immunotherapies

(2015) Lorenzo Galluzzi et al.   Oncotarget

HTSeq--a Python framework to work with high-throughput sequencing data

(2014) S. Anders et al.   BIOINFORMATICS

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

(2014) Matthew M. Gubin et al.   NATURE

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing

(2014) Mahesh Yadav et al.   NATURE

The nature and extent of contributions by defective ribosome products to the HLA peptidome

(2014) D. Bourdetsky et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Leveraging the complementary nature of RNA-Seq and shotgun proteomics data

(2014) Xiaojing Wang et al.   PROTEOMICS

Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides

(2014) Diana Paola Granados et al.   Nature Communications

Cause and Consequence of Cancer/Testis Antigen Activation in Cancer

(2013) Angelique W. Whitehurst   Annual Review of Pharmacology and Toxicology

Immunological challenges for peptide-based immunotherapy in glioblastoma

(2013) Malte Mohme et al.   CANCER TREATMENT REVIEWS

LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma

(2013) J. T. Yeung et al.   CLINICAL CANCER RESEARCH

HLA ligandome tumor antigen discovery for personalized vaccine approach

(2013) Hans-Georg Rammensee et al.   Expert Review of Vaccines

ERAAP and Tapasin Independently Edit the Amino and Carboxyl Termini of MHC Class I Peptides

(2013) T. Kanaseki et al.   JOURNAL OF IMMUNOLOGY

HLA Peptide Length Preferences Control CD8+ T Cell Responses

(2013) M. J. Rist et al.   JOURNAL OF IMMUNOLOGY

The Effect of Proteasome Inhibition on the Generation of the Human Leukocyte Antigen (HLA) Peptidome

(2013) Elena Milner et al.   MOLECULAR & CELLULAR PROTEOMICS

Reassessing target antigens for adoptive T-cell therapy

(2013) Christian S Hinrichs et al.   NATURE BIOTECHNOLOGY

MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements

(2012) D. P. Granados et al.   BLOOD

Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications

(2012) S Coral et al.   BRITISH JOURNAL OF CANCER

The cancer antigenome

(2012) Bianca Heemskerk et al.   EMBO JOURNAL

Proteome Sampling by the HLA Class I Antigen Processing Pathway

(2012) Ilka Hoof et al.   PLoS Computational Biology

Origin and plasticity of MHC I-associated self peptides

(2011) Danielle de Verteuil et al.   AUTOIMMUNITY REVIEWS

Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

(2011) Claus Lundegaard et al.   Expert Review of Vaccines

Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment

(2011) Jürgen Cox et al.   JOURNAL OF PROTEOME RESEARCH

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

(2011) Veerauo V Konkankit et al.   Journal of Translational Medicine

The Human Immunopeptidome Project, a Suggestion for yet another Postgenome Next Big Thing

(2011) Arie Admon et al.   MOLECULAR & CELLULAR PROTEOMICS

The biology of cancer testis antigens: Putative function, regulation and therapeutic potential

(2011) Elisabetta Fratta et al.   Molecular Oncology

Global quantification of mammalian gene expression control

(2011) Björn Schwanhäusser et al.   NATURE

Deletion of Immunoproteasome Subunits Imprints on the Transcriptome and Has a Broad Impact on Peptides Presented by Major Histocompatibility Complex I molecules

(2010) Danielle de Verteuil et al.   MOLECULAR & CELLULAR PROTEOMICS

TopHat: discovering splice junctions with RNA-Seq

(2009) Cole Trapnell et al.   BIOINFORMATICS

BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources

(2009) Chunlei Wu et al.   GENOME BIOLOGY

The DNA demethylating agent 5-aza-2′-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma

(2008) Atsushi Natsume et al.   INTERNATIONAL JOURNAL OF CANCER

The MHC class I peptide repertoire is molded by the transcriptome

(2008) Marie-Hélène Fortier et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Selected reaction monitoring for quantitative proteomics: a tutorial

(2008) Vinzenz Lange et al.   Molecular Systems Biology

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

(2008) Jürgen Cox et al.   NATURE BIOTECHNOLOGY

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

(2008) L. G. Almeida et al.   NUCLEIC ACIDS RESEARCH